177Lu-DOTATATE

Lutetium-177 dotatate · Ipsen

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for 177Lu-DOTATATE, covering 2020-02-07 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma [Phase 2]